In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights advancements in colorectal cancer research, collaborative efforts in prostate cancer studies, recent research grant recipients, new podcast episodes, lung cancer research and prevention initiatives, brain cancer discoveries, leadership transitions, and the critical role of clinical trials. Read More
April 7, 2025: This month, the Big Ten Cancer Research Consortium highlights Indiana University Melvin and Bren Simon Comprehensive Cancer Center (IUSCCC) as our featured member. Misty Dawn Shields, MD, PhD, is an IUSCCC associate member of the Experimental and Developmental Therapeutics research program and assistant professor of clinical medicine. Dr. Shields joined faculty at IUSCCC in August 2022 as a physician scientist with a focus in early phase trials, longitudinal liquid biopsies, and translational studies for novel therapeutics in acquired chemo-resistant small cell lung cancer (SCLC) as principal investigator of the Shields laboratory. Additionally, Dr. Shields serves on the... Read More
March 25, 2025: The Indianapolis Business Journal (IBJ) and Inside Indiana Business (IIB) recently interviewed Brian Stemme, CEO of Hoosier Cancer Research Network, which serves as the consortium’s administrative headquarters, for separate pieces highlighting the Big Ten Cancer Research Consortium. The IBJ also interviewed Dr. Nabil Adra, a genitourinary medical oncologist at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Big Ten CRC Steering Committee representative for Indiana University. Both pieces tied into local events this month, as the city of Indianapolis hosted the Big Ten men’s and women’s basketball tournaments. The IBJ article can be found here: Read More
March 17, 2025: We are thrilled to reintroduce Across the Consortium, a monthly article showcasing the latest news and events from our member institutions. In this edition, we proudly add our newest member, Fred Hutchinson Cancer Center, which serves as the cancer program for UW Medicine—the University of Washington’s health system—joining our consortium of now 16 institutions. Read More
February 11, 2025: The Big Ten Cancer Research Consortium (Big Ten CRC), a collaboration of the cancer centers of Big Ten Conference universities united to transform cancer research by leveraging their scientific and clinical expertise, welcomed new member Fred Hutch Cancer Center, an independent, nonprofit organization that serves as the cancer program for UW Medicine (the University of Washington’s health system). It is the first new institution to join the consortium following the recent expansion of the Big Ten Conference. Read More
December 17, 2024: A Big Ten Cancer Research Consortium trial, BTCRC-LYM20-463, titled, "A Phase I/II Study of Tazemetostat Combined with Abbreviated Rituximab/Bendamustine Therapy for High Tumor Burden Follicular Lymphoma in Frontline Treatment: A Big Ten Cancer Research Consortium Study," was presented as a poster presentation at the 2024 American Society of Hematology Annual Meeting on December 9, 2024. Congratulations to Vaishalee P Kenkre, MD, of the University of Wisconsin School of Medicine and Public Health, Andrew M Evens, DO, MBA, MSc, of Rutgers Cancer Institute and all co-authors! Read More
December 6, 2024: A Big Ten Cancer Research Consortium (Big Ten CRC) trial titled, “A Phase II Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients: Big Ten Cancer Research Consortium BTCRC-BRE16-042” has been accepted as a poster presentation (P2-07-21) at the 2024 San Antonio Breast Cancer Symposium on December 11, 2024 from 5:30 pm – 7:30 pm. Congratulations to all co-authors and study teams involved in the study! Read More
December 4, 2024: A Big Ten Cancer Research Consortium trial titled, “Alpelisib (BYL719) with continued endocrine therapy following progression on endocrine therapy in hormone receptor–positive, HER2-negative, PIK3CA-mutant metastatic breast cancer: A Big Ten Cancer Research Consortium Study (BTCRC-BRE19-409)” has been accepted for a poster presentation at the 2024 San Antonio Breast Cancer Symposium on December 11, 2024 from 5:30 pm – 7:00 pm. Congratulations to all co-authors and study teams involved in the study! Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube